ArticleExperimental and therapeutic medicine2015

Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury.

Ren Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.